Comments: US HB6710 | 2021-2022 | 117th Congress

Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.

Spectrum: Partisan Bill (Republican 21-0)

Status: (Introduced - Dead) 2022-02-14 - Referred to the Subcommittee on Health. [HB6710 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB6710 at this time.

Social Comments on US HB6710

feedback